A new study presented recently at the 2017 Annual Meeting of the American College of Rheumatology identifies four factors that may predict whichrheumatoid arthritis (RA)patients might successfully taper the dose of their biologic medication.

Althoughbiologicsare highly effective in controlling RA and its symptoms, patients in some cases prefer not to use them.Past studieshave shown that it is possible to taper and even stop the medication in certain patients who are in remission once they have been successfully treated with one of these drugs.

Continue readingResearch Identifies Which RA Patients May Successfully Reduce Their Biologics→